v3.25.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Summary of Revenue Significant Expenses and Net Loss for Segment

The following table presents revenue, significant expenses and net loss for the Company's segment (in thousands):

 

 

Three Months Ended
March 31,

 

 

 

2025

 

 

2024

 

Collaboration revenue

 

$

183

 

 

$

532

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

Clinical related costs

 

 

1,286

 

 

 

5,961

 

Employee related costs

 

 

3,075

 

 

 

9,475

 

Product development and manufacturing costs

 

 

133

 

 

 

1,483

 

Facilities, support costs and depreciation

 

 

2,672

 

 

 

4,065

 

Professional, consulting and public company costs

 

 

973

 

 

 

3,072

 

Restructuring and other related charges

 

 

885

 

 

 

 

Total operating expenses

 

 

9,024

 

 

 

24,056

 

Loss from operations

 

 

(8,841

)

 

 

(23,524

)

Other income:

 

 

 

 

 

 

Interest income

 

 

298

 

 

 

1,086

 

Total other income

 

 

298

 

 

 

1,086

 

Loss before income tax expense

 

 

(8,543

)

 

 

(22,438

)

Income tax expense

 

 

(4

)

 

 

(14

)

Net loss

 

$

(8,547

)

 

$

(22,452

)